EXPD-101
Asset
- Stage
- Phase 2
- Modality
- Other
- Target
- Not known
- 3
- Indications
- 1
- Trial
- 1
- Developer
Indications
3Chronic obstructive pulmonary disease
Phase 2, Not yet recruiting, CTIS2026-525216-34-00, euclinicaltrials.eu, 10 Oct 2026
Chronic obstructive pulmonary disease (copd) exacerbations
Phase 2, Not yet recruiting, CTIS2026-525216-34-00, euclinicaltrials.eu, 10 Oct 2026
Chronic obstructive pulmonary disease exacerbation
Phase 2, Not yet recruiting, CTIS2026-525216-34-00, euclinicaltrials.eu, 10 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors3
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.